Navigation Links
Accelerate Diagnostics Announces Final Terms of Rights Offering
Date:7/12/2013

TUCSON, Ariz., July 12, 2013 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX), an in vitro diagnostics company dedicated to providing solutions for the global challenge of drug resistant organisms and hospital acquired infections, announced today the final terms of its previously announced $20,000,000 rights offering.  The Company anticipates that the rights offering will commence with the distribution of the final prospectus and related materials to stockholders on or about July 18, 2013.

Under the terms of the rights offering, the Company is distributing, at no charge to the holders of its common stock as of 5:00 p.m., New York City time, on July 8, 2013, which was established as the record date for the rights offering, 0.064038 non-transferable subscription rights for each share of common stock owned on the record date, as more fully described in the prospectus relating to the rights offering.  Each whole subscription right will allow the holder thereof to subscribe to purchase one share of common stock at a subscription price of $8.04 per share.  In addition, any holder of subscription rights exercising his, her or its basic subscription privilege in full will be eligible to subscribe to purchase additional shares of common stock at the same subscription price per share, subject to the conditions and limitations described further in the prospectus.  In the aggregate, the Company intends to issue up to 2,487,562 shares of common stock in connection with the rights offering.

The subscription rights may be exercised until 5:00 p.m. New York City time, on August 7, 2013, as more fully described in the prospectus.  The rights offering period may not be extended.  Any fractional rights remaining after aggregating all of the subscription ri
'/>"/>

SOURCE Accelerate Diagnostics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
2. University Hospitals Case Medical Centers Harrington Discovery Institute Launches Grant Program to Accelerate Drug Discovery and Development
3. ZyDoc Selects Health Fidelitys REVEAL™ Natural Language Processing (NLP) Platform to Accelerate Time to Value for its MediSapien Web Services
4. Berg Pharma and the Parkinsons Institute ink R&D collaboration to drive disease understanding and accelerate therapeutic and diagnostic development in Parkinsons Disease
5. PAREXEL And Korea Drug Development Fund Announce Alliance To Accelerate Global Drug Development And Commercialization
6. Sigma-Aldrich Accelerates Analytical Research and Extends Benefits of Fused-Core Particle Technology to All HPLC Users with the Launch of New Ascentis Express 5 Micron Particle by Supelco
7. Medical Alarm Provides Investor Update -- Company Surpassing Previous Record Order Levels as Consumer Interest Accelerates
8. Medical Devices Market in China to 2018 - Government Reforms Aimed at Strengthening the Healthcare System and Expanding Access will Accelerate Growth
9. Questcor Pharmaceuticals Accelerates Cash Dividend; Payment Date Set for December 21, 2012
10. Emerging Pharmaceutical Market in South Africa - Proposed Introduction of New Drug Regulatory Agency (SAHPRA) to Accelerate Drug Registration Process
11. Novel Biomaterials Accelerate the Development of Innovative Wound Care Management Technologies, Finds Frost & Sullivan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... HILL, S.C. , Sept. 18, 2014   3D ... addition of the Simbionix RobotiX Mentor™ , a new ... shown for the first time at the ERUS exhibition in ... to 19 (booth #7). Robotic-assisted minimally invasive surgery ... increased demand means the needs for training for robotic surgery ...
(Date:9/18/2014)... , Sept. 18, 2014 Veterinary biologic ... Dr. Ashraf Hanna , M.D., Ph.D., and Dr. ... of Directors. Dr. Hanna is the Vice President of ... Financial Officer for the Genentech Foundation, while Dr. McCracken ... of Business Development and Licensing for Roche Pharma. ...
(Date:9/18/2014)... Mass. , Sept. 18, 2014  Spring ... novel therapeutics for the treatment of RNA viruses, ... Institutes of Health (NIH) for animal testing of ... viral pathogens, classified as "Special Pathogens," against which ... 9200, derived from Spring Bank,s proprietary ...
Breaking Medicine Technology:3D Systems Introduces New Simbionix Robotics Training Platform 23D Systems Introduces New Simbionix Robotics Training Platform 3Nexvet Appoints Ashraf Hanna and Joseph McCracken to Board of Directors 2Nexvet Appoints Ashraf Hanna and Joseph McCracken to Board of Directors 3Spring Bank Pharmaceuticals Announces NIH Collaboration for Testing of SB 9200 Against Multiple Viral Pathogens 2
... MYRTLE BEACH, S.C., Sept. 19, 2011 Laser ... has received an FDA approval for its revolutionary laser ... treats pain through nerve tissue regeneration. ... trigeminal nerve in the face. The trigeminal nerve (the ...
... 19, 2011 Bayer HealthCare, one of the world,s ... to support the Women,s International Leadership (WIL) Program at ... that Bayer HealthCare has established as part of its ... to further develop an environment that fosters the development ...
Cached Medicine Technology:FDA Approved, Non-Invasive Laser Is A Success in Trigeminal Neuralgia Pain Treatment 2International House and Bayer HealthCare Partner to Prepare Women for Leadership Positions 2International House and Bayer HealthCare Partner to Prepare Women for Leadership Positions 3
(Date:9/18/2014)... 2014 Limited spots remain at Becker's ... 100 spots are still available for Becker's ASC 21st ... on October 23-25, 2014 at the Swissotel Chicago. , ... Information Officer Strategy Roundtable on November 4, 2014 at ... for Becker's Hospital Review Chief Executive Officer Strategy Roundtable ...
(Date:9/18/2014)... Angeles, CA (PRWEB) September 18, 2014 ... manufacture and refine carbon dioxide, selling it to downstream ... largest markets for carbon dioxide are food and beverage ... products, such as fruits, vegetables or pizzas. The gas ... Beverage manufacturers use the compound to carbonate soft drinks, ...
(Date:9/18/2014)... Amy Norton HealthDay Reporter , ... dose of a common antidepressant can quickly alter the way ... The findings, reported online Sept. 18 in Current ... response to widely prescribed antidepressants. Experts said the hope is ... are likely to benefit from a drug -- and which ...
(Date:9/18/2014)... Chest Physicians (CHEST) together with the Chinese Thoracic ... of CTS that CHEST World Congress 2016 will ... critical care, and sleep medicine from around the ... slated for spring 2016. , CHEST World ... hands-on simulation training, keynote addresses, presentations by leading ...
(Date:9/18/2014)... Thousands of college and high school ... fundraising impact on 127 member Children’s Miracle Network ... Dance Marathon Day will officially kick off a school ... raised by college and high school students funding vital ... Dance Marathon campus programs help provide medical equipment, treatment ...
Breaking Medicine News(10 mins):Health News:Limited Spots Remain at Becker's Upcoming ASC and Hospital Conferences 2Health News:Carbon Dioxide Production in the US Industry Market Research Report Now Available from IBISWorld 2Health News:Carbon Dioxide Production in the US Industry Market Research Report Now Available from IBISWorld 3Health News:One Dose of Antidepressant Changes Brain Connections, Study Says 2Health News:One Dose of Antidepressant Changes Brain Connections, Study Says 3Health News:CHEST announces China as site of CHEST World Congress 2016 2Health News:250 Campuses Usher in School Year of Saving Kids’ Lives During First-Ever “Dance Marathon Day” on Sept. 25 2
... ShopAtHome.com, a leading Free Coupon and Cash Back ... 1, 2009 to help shoppers shop, save, and donate! ... Komen for the Cure® as part of a month-long ... http:// href="http://www.newscom.com/cgi-bin/prnh/20091001/LA85003LOGO"> www.newscom.com/cgi-bin/prnh/20091001/LA85003LOGO ) , ...
... CITY, Mo., Oct. 1 DST Systems, Inc. (NYSE: ... Company has entered into separate privately negotiated exchange agreements ... principal of the Company,s outstanding 4.125% Series A Convertible ... in aggregate principal of new 4.125% Series C Convertible ...
... recent study published in the October 2009 issue of the ... specific genetic markers identified in previous research, or SNPs, may ... in whites. The genes CHRNA3 and CHRNA5 may contribute to ... nicotine dependence. Although their presence is less frequent in African ...
... Many patients urgently admitted to hospital with cerebral infarction ... prolonged period prior to suffering their stroke, is shown ... the Sahlgrenska Academy at the University of Gothenburg and ... published in the scientific journal BMC Medicine . ...
... they get less sleep than they actually do, study finds ... longer and better than older men, even though many women ... found. , The study of 956 people, aged 59 to ... men on all of the self-reported measures, including a 13.2 ...
... Attacks New York Department of ,Hype, with New York Times Ad ... (CCF) is running a full-page ad in the New York Times ... Department of Health,s hyperbolic "Don,t drink yourself fat" PSA campaign. The Center ... News and New York Post that ask New Yorkers, ...
Cached Medicine News:Health News:ShopAtHome.com Helps Shoppers Save Money and Support Breast Cancer Research 2Health News:DST Systems, Inc. Announces Exchange Transaction Involving 4.125% Series A Convertible Senior Debentures 2Health News:Lung cancer risk increases with expression of specific genes 2Health News:Severe stress can cause stroke 2Health News:Older Women May Sleep Better Than Men 2Health News:Consumer Group Continues Million Dollar Campaign Responding to NYC Health Officials' Hyperbolic PSA Campaign 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: